DeepMed Research

University of Turku

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1920-01-01

Employees: 3.2K

Market Cap: -

Website: http://www.utu.fi

Clinical Trials

CRAGS (Coronary aRtery diseAse in younG adultS)

Conditions: Coronary Artery Bypass Grafting
Percutaneous Coronary Intervention
Coronary Artery Disease
Young Patient
Acute Coronary Syndromes

First Posted Date: 2013-04-24

Last Posted Date: 2015-05-28

Lead Sponsor: University of Turku

Target Recruit Count: 2000

Registration Number: NCT01838746

Locations: 🇫🇮
Turku University Hospital, Turku, Finland
🇮🇹
University of Catania, Catania, Italy
🇮🇹
University of Verona Medical School, Verona, Italy

and more 6 locations

Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline

Phase 1

Completed

Conditions: Changes in Striatal [11C]ORM-13070 Binding.

Interventions: Drug: Ketamine
Drug: Atomoxetine
Drug: Placebo
Other: Cold pressor test

First Posted Date: 2013-02-20

Last Posted Date: 2013-02-20

Lead Sponsor: University of Turku

Target Recruit Count: 8

Registration Number: NCT01794975

Locations: 🇫🇮
Clinical Research Services Turku (CRST) / Turku PET Centre, Turku, Finland

Screening Versus Routine Practice in Detection of Atrial Fibrillation in the Elderly Population of Lieto

Not Applicable

Conditions: Atrial Fibrillation
Stroke

Interventions: Other: Subject education to pulse palpation

First Posted Date: 2012-11-02

Last Posted Date: 2014-05-08

Lead Sponsor: University of Turku

Target Recruit Count: 200

Registration Number: NCT01721005

Locations: 🇫🇮
Härkätie community health center, Lieto, Finland

LGG/BB12-pastille Study

Phase 1

Completed

Conditions: Probiotics

Interventions: Dietary Supplement: Probiotics in an pastille
Dietary Supplement: Control pastille

First Posted Date: 2012-04-13

Last Posted Date: 2013-01-04

Lead Sponsor: University of Turku

Target Recruit Count: 60

Registration Number: NCT01577485

Locations: 🇫🇮
Institute of Dentistry, Turku, Finland

Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ketamine
Drug: Insulin
Other: Cold pressor test
Drug: Placebo
Drug: Atipamezole
Drug: Atomoxetine

First Posted Date: 2011-09-16

Last Posted Date: 2013-02-18

Lead Sponsor: University of Turku

Target Recruit Count: 10

Registration Number: NCT01435213

Locations: 🇫🇮
University of Turku, Clinical Research Services Turku CRST, Turku, Finland
🇫🇮
University of Turku, Turku PET Centre, Turku, Finland

Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

Phase 2

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: colecalciferol

First Posted Date: 2011-09-13

Last Posted Date: 2011-09-13

Lead Sponsor: University of Turku

Target Recruit Count: 70

Registration Number: NCT01432704

Does Administration of Probiotics During Infancy Increase the Caries Risk of a Child

Not Applicable

Withdrawn

Conditions: Dental Caries

Interventions: Dietary Supplement: Probiotics in infant milk formula

First Posted Date: 2011-08-29

Last Posted Date: 2012-02-22

Lead Sponsor: University of Turku

Registration Number: NCT01424852

Locations: 🇫🇮
University of Turku, Turku, Finland

Vascular Healing of DES at 3 Months

Completed

Conditions: Acute Coronary Syndrome

Interventions: Device: OCT
Device: Transthoracic echocardiography CFR measurement

First Posted Date: 2011-07-12

Last Posted Date: 2013-08-02

Lead Sponsor: University of Turku

Target Recruit Count: 46

Registration Number: NCT01391871

Locations: 🇫🇮
Satakunta Central Hospital, Pori, Pori, Finland
🇫🇮
Turku University Hospital, Turku, Finland

Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

Phase 4

Conditions: Multiple Sclerosis

Interventions: Drug: Placebo capsules
Drug: Colecalciferol

First Posted Date: 2011-04-21

Last Posted Date: 2011-05-19

Lead Sponsor: University of Turku

Target Recruit Count: 70

Registration Number: NCT01339676

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events

Completed

Conditions: Associations Between Genetic Data and Docetaxel Toxicity
CYP3A Phenotyping
Docetaxel Toxicity
CYP3A5 and MDR1 Genotyping

Interventions: Drug: docetaxel + CEF

First Posted Date: 2010-04-26

Last Posted Date: 2010-04-27

Lead Sponsor: University of Turku

Target Recruit Count: 20

Registration Number: NCT01110291

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy